Population or sample, inclusion and exclusion criteria
neurological deficits, cervical cancer, motor or cognitive deficits
ADVERSE EVENTS, CERVICAL CANCER
Fifty-two women with cervical cancer who were recently admitted to the radiation therapy service were included in the study. Sample size calculation (71 participants) based on simple dimensioning was based on the mean (86 cases) of women who underwent radiochemotherapy from 2016 to 2018, with a margin of error of 5% and confidence level of 95%. Inclusion criteria were age over 18 years and indication of treatment for cervical cancer with radiochemotherapy.Exclusion criteria included hospitalized women, those undergoing pelvic re-irradiation, those using antidepressants and psychotropic drugs, those with neurological deficits (motor or cognitive deficits recorded in the medical record), and those using integrative practices (such as yoga, meditation, among others). Discontinuation criteria were: initiation of antidepressants and anxiolytics during the study period, interruption of radiochemotherapy or failure to complete the intervention protocol sessions. However, there was no loss of follow-up and no reports of adverse events, side effects, or protocol deviations.